Clinical Research

Showing 1547 articles
Business

ACADIA Pharmaceuticals: A Deep Value Play or a Value Trap?

After a significant rebound, ACADIA Pharmaceuticals (ACAD) shares present a conundrum for investors. While a discounted cash flow model suggests deep undervaluation, the stock's volatile history and mixed performance metrics demand a closer look at the underlying narrative.

Business

Bridgestone's Stock: A Year of Strong Gains Raises Valuation Questions

Bridgestone Corporation's shares have delivered a robust 33% total return to shareholders over the past year, outpacing its recent short-term volatility. This performance prompts a closer look at whether the tire giant's current valuation still offers room for growth or if the market has already priced in its future prospects.

Business

Singapore Airlines Charts Steady Course Amid Industry Headwinds, Focus on Capital Efficiency

Singapore Airlines (SGX:C6L) is demonstrating a disciplined approach to capital allocation, with a notable uptick in its return on capital employed (ROCE). While its current 6.3% return lags behind the broader airline industry average, the trend signals a potential turning point for the carrier as it seeks to solidify its post-pandemic recovery and build sustainable long-term value for shareholders.

Business

Argan, Inc. (AGX): The Quiet Powerhouse in Energy Infrastructure

Argan, Inc., a specialized engineering and construction firm, is drawing investor attention with its robust financial performance, zero-debt balance sheet, and strategic positioning in the evolving energy sector. Despite a premium valuation, its record backlog and cash-generating prowess present a compelling bull case.